StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) stock

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.78+0.01 (+1.18%)

Close on Nov 17, 2026Market cap $9.26MP/E –Yield –

How the market prices CytoMed Therapeutics

Each ratio against its own distribution since 2023, from month-end prices and the figures reported at the time

CytoMed Therapeutics trades at 1.8× its earnings, against a median of 3.2× since 2023 — cheaper than 98% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2023, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to book since 2023

Median 3.2×, today 1.8×

What CytoMed Therapeutics keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

EBITDA margin-1111.1%
Pretax margin-1232.0%
Net margin-1227.1%
Free cash flow margin-1336.5%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity-51.3%
Return on assets-44.1%

How hard the assets work

Revenue per dollar of assets0.04
Revenue per employee64.88K SGD
Profit per employee-796.09K SGD

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by 1.69M SGD. That is 13.0% of the 10.55M SGD it would cost to buy the business outright.

Total debt409.50K SGD
Cash and short-term investments2.10M SGD
EBITDA, trailing twelve months-3.60M SGD
Free cash flow, trailing twelve months-4.34M SGD

Leverage and liquidity

Debt to equity0.06
Current ratio5.17
Quick ratio5.17

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

3.51
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

1 of 9 tests passed

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield-33.4%
Free cash flow yield-36.3%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

35
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

GDTCS&P 500
PeriodGDTCS&P 500DifferenceGDTC per yearS&P 500 per year
1 month-11.0%-4.0%−7.0 pts
3 months-13.6%-5.0%−8.6 pts
Year to date-41.3%+8.2%−49.6 pts
1 year-60.5%+11.2%−71.7 pts
3 years-79.0%+68.5%−147.4 pts-40.5%+19.0%

How much it moves

Volatility, 1 year91.5%
Volume against its 90-day average0.32

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M GDTC shares were sold short on Oct 30, 2026, down 9.0% from the previous report. At recent volumes it would take 1.8 days to buy them back. Over the last 20 sessions, 40.4% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Days of volume to buy it back1.81

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202617,603-9.0%9,7451.8
Oct 15, 202619,350+13.1%24,6931.0
Sep 30, 202617,102+372.4%15,9861.1
Sep 15, 20263,620-43.2%11,0461.0
Aug 31, 20266,370+51.4%22,5191.0
Aug 14, 20264,207-25.6%30,0241.0
Jul 31, 20265,655-81.2%329,1451.0
Jul 15, 202630,057-20.7%9,9183.0
Jun 30, 202637,906-17.6%12,8503.0
Jun 15, 202646,008-32.3%23,1372.0
May 29, 202667,963-4.4%29,9862.3
May 15, 202671,090+4.3%26,4692.7

Every measure, in full

63 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Dec 31, 2025
Share price as of
–

Valuation ratiosIndustry

Market Cap
11.93M SGD
–
Enterprise Value
10.55M SGD
–
PS Ratio
36.78
–
PB Ratio
1.82
–
P/TBV Ratio
1.86
–

Enterprise valuationIndustry

EV / Sales
32.54
–

Share statisticsIndustry

Shares Change (YoY)
0.93%
–
Float
9M
–
Shares Held by Insiders
25.9%
–
Shares Held by Institutions
0.10%
–

Short sellingIndustry

Short Interest
17,603
–
Short Interest Change
-9.03%
–
Days to Cover
1.81
–

Stock price statisticsIndustry

Price Change (1 Week)
-6.33%
–
Price Change (1 Month)
-8.10%
–
Price Change (3 Months)
-13.0%
–
Price Change (6 Months)
-35.3%
–
Price Change (YTD)
-41.3%
–
Price Change (1 Year)
-60.1%
–
Price Change (3 Years)
-79.0%
–
Average Volume (10 Days)
12,907
–
Average Volume (20 Days)
13,014
–
Average Volume (90 Days)
60,524
–
Relative Volume
0.32
–
Relative Strength Index (14)
35.5
–
Volatility (1 Year)
91.5%
–

MarginsIndustry

Pretax Margin
-1232.0%
–
Profit Margin
-1227.1%
–
EBITDA Margin
-1111.1%
–
FCF Margin
-1336.5%
–

Returns on capitalIndustry

Return on Equity (ROE)
-51.3%
–
Return on Assets (ROA)
-44.1%
–

Financial positionIndustry

Current Ratio
5.17
–
Quick Ratio
5.17
–
Debt / Equity
0.06
–

GrowthIndustry

Revenue Growth (YoY)
366.7%
–

EfficiencyIndustry

Asset Turnover
0.04
–
Revenue Per Employee
64.88K SGD
–
Profits Per Employee
-796.09K SGD
–
Employee Count
5
–

Income statement (TTM)Industry

Revenue
324.39K SGD
–
Pretax Income
-4.00M SGD
–
Net Income
-3.98M SGD
–
EBITDA
-3.60M SGD
–
EPS (Diluted)
-0.34 SGD
–

Balance sheetIndustry

Total Debt
409.50K SGD
–
Net Cash (Debt)
1.69M SGD
–
Net Cash Per Share
0.14 SGD
–
Equity (Book Value)
6.54M SGD
–
Book Value Per Share
0.55 SGD
–
Tangible Book Value
6.42M SGD
–
Working Capital
2.95M SGD
–

Cash flow (TTM)Industry

Operating Cash Flow
-3.70M SGD
–
Capital Expenditures
-637.85K SGD
–
Free Cash Flow
-4.34M SGD
–
FCF Per Share
-0.37 SGD
–

Dividends and yieldsIndustry

Earnings Yield
-33.4%
–
FCF Yield
-36.3%
–

Taxes and interestIndustry

Interest Expense
20.91K SGD
–

Scores and fair valueIndustry

Altman Z-Score
3.51
–
Piotroski F-Score
1
–

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?